Micah Girotti, MD
Vascular Surgery · Bel Air, MDNPI 1780847400
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Medtronic at 59.5% of the total. 2025 is the largest year on record at $29,907, more than ten times the $157 reported in 2019. Among vascular surgery clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 171 payments — averaging $202.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$21K
- Angiodynamics, Inc.$9K
- Penumbra, Inc.$1K
- Bard Peripheral Vascular, Inc.$935
- Philips North America LLC$660
- Silk Road Medical, Inc.$416
- plus $2K from 11 others
What the payments were for
- Speaking & faculty fees$18,40053%
- Travel & lodging$8,45124%
- Food & beverage$7,73922%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 48 | $20,568 |
| Angiodynamics, Inc. | 34 | $8,983 |
| Penumbra, Inc. | 6 | $1,095 |
| Bard Peripheral Vascular, Inc. | 23 | $935 |
| Philips North America LLC | 8 | $660 |
| Silk Road Medical, Inc. | 6 | $416 |
| Nevro Corp. | 4 | $413 |
| W. L. Gore & Associates, Inc. | 6 | $387 |
| Boston Scientific | 15 | $371 |
| Shockwave Medical, Inc | 1 | $218 |
| Abbott | 6 | $188 |
| Johnson & Johnson | 6 | $137 |
| Cook Medical LLC | 4 | $76 |
| Nipro Medical Corporation | 1 | $58 |
| Biocomposites Inc | 1 | $45 |
| EKOS Corporation | 1 | $25 |
| Cardinal Health 200 LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Abre$18,557
- Auryon Laser System 100-120 Vac$5,973
- AngioVac$1,781
- Indigo System$1,030
- VenaSeal$676
- AlphaVac$641
- ENROUTE Transcarotid Neuroprotection System$491
- (9520) IGT Devices Undivided$378
- ENROUTE Transcarotid Stent$359
- GORE TAG Conformable Thoracic Endoprosthesis$319
- RotarexS 6 F x 135 cm$242
- Senza$227
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$218
- Lutonix Drug Coated Balloon$138
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$131
- Varithena Administration Pack$123
- ELLIPSYS VASCULAR ACCESS SYSTEM$121
- ENROUTE .014 Guidewire$103
- ENHANCE Transcarotid Peripheral Access Kit$103
How this compares
$34,591 in reported general payments places this provider in the 90th percentile of 104 vascular surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 54 | $49,710 |
| ClopidogrelClopidogrel Bisulfate | 113 | $1,475 |
| Cilostazol | 11 | $385 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $137 | $49,71054 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 104 vascular surgery providers in Maryland.
Other vascular surgery in Bel Air
- Michael OsgoodBel Air$57K
- Richard BaffordBel Air$31K
- Andre BiuckiansBel Air$24K
- Philip RiveraBel Air$4K
- Peter MackrellBel Air$3K
- Paul McNeillFrederick$302K
- John MartinAnnapolis$172K
- Caitlin HicksBaltimore$88K
- Shahab ToursavadkohiBaltimore$76K
- Jeffrey WangGermantown$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.